Catechol-O-methyltransferase, an enzyme that breaks down dopamine and l-dopa in the brain and thus reduces the effectiveness of some treatments for Parkinson's disease. Drugs that inhibit COMT improve patient responsiveness to treatment with levodopa, one of the mainstays of treatment for Parkinson's disease.